FDA fully approves 'novel' Alzheimer’s disease drug Leqembi, will be covered by Medicare
Fox News
Leqembi, a drug that can help treat adult patients with Alzheimer’s, was given traditional approval by the FDA on Thursday. It was first approved in January for clinical trials.
"Leqembi is the first amyloid beta-directed antibody to be converted from an accelerated approval to a traditional approval for the treatment of Alzheimer’s disease," the FDA explained in a press release.
"The drug works by reducing amyloid plaques that form in the brain, a defining pathophysiological feature of the disease," the statement added.
More Related News
Critically endangered whale seen off California coast: 'Every sighting is incredibly valuable to us'
In a rare sighting recently, the endangered North Pacific right whale was spotted off the coast of California by a marine wildlife team near Cordell Bank National Marine Sanctuary.